OLANZACCORD TABLETS 2.5 mg olanzapine 2.5 mg film-coated tablet blister pack Australia - englanti - Department of Health (Therapeutic Goods Administration)

olanzaccord tablets 2.5 mg olanzapine 2.5 mg film-coated tablet blister pack

accord healthcare pty ltd - olanzapine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; hyprolose; lactose monohydrate; microcrystalline cellulose; crospovidone; hypromellose; titanium dioxide; polysorbate 80; macrogol 400 - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses. ,olanzapine tablets alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,olanzapine tablets are also indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

OLANZACCORD TABLETS 7.5 mg olanzapine 7.5 mg film-coated tablets blister pack Australia - englanti - Department of Health (Therapeutic Goods Administration)

olanzaccord tablets 7.5 mg olanzapine 7.5 mg film-coated tablets blister pack

accord healthcare pty ltd - olanzapine, quantity: 7.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; crospovidone; magnesium stearate; hypromellose; hyprolose; titanium dioxide; polysorbate 80; macrogol 400 - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses. ,olanzapine tablets alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,olanzapine tablets are also indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

DOSTINEX cabergoline 0.5mg tablet bottle Australia - englanti - Department of Health (Therapeutic Goods Administration)

dostinex cabergoline 0.5mg tablet bottle

pfizer australia pty ltd - cabergoline, quantity: 0.5 mg - tablet, uncoated - excipient ingredients: leucine; lactose - indications as at 10 june 2004 : inhibition of physiological lactation - dostinex is indicated for the prevention of the onset of physiological lactation in the puerperium for clearly defined medical reasons. treatment of hyperprolactinemic disorders - dostinex is indicated for the treatment of pathological hyperprolactinaemia.

OZIN 10 olanzapine 10 mg tablets bottle Australia - englanti - Department of Health (Therapeutic Goods Administration)

ozin 10 olanzapine 10 mg tablets bottle

strides pharma science pty ltd - olanzapine, quantity: 10 mg - tablet, uncoated - excipient ingredients: magnesium stearate; hyprolose; lactose monohydrate; crospovidone - olanzapine is indicated for the treatment of schizophrenia and related psychoses. ,olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

OZIN 7.5 olanzapine 7.5 mg tablets bottle Australia - englanti - Department of Health (Therapeutic Goods Administration)

ozin 7.5 olanzapine 7.5 mg tablets bottle

strides pharma science pty ltd - olanzapine, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; crospovidone; magnesium stearate; hyprolose - olanzapine is indicated for the treatment of schizophrenia and related psychoses. ,olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

OZIN 5 olanzapine 5 mg tablets bottle Australia - englanti - Department of Health (Therapeutic Goods Administration)

ozin 5 olanzapine 5 mg tablets bottle

strides pharma science pty ltd - olanzapine, quantity: 5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; hyprolose; crospovidone - olanzapine is indicated for the treatment of schizophrenia and related psychoses. ,olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

OZIN 2.5 olanzapine 2.5 mg tablets bottle Australia - englanti - Department of Health (Therapeutic Goods Administration)

ozin 2.5 olanzapine 2.5 mg tablets bottle

strides pharma science pty ltd - olanzapine, quantity: 2.5 mg - tablet, uncoated - excipient ingredients: hyprolose; magnesium stearate; lactose monohydrate; crospovidone - olanzapine is indicated for the treatment of schizophrenia and related psychoses. ,olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

OLANZAPINE SANDOZ olanzapine 7.5mg film coated tablet, blister pack Australia - englanti - Department of Health (Therapeutic Goods Administration)

olanzapine sandoz olanzapine 7.5mg film coated tablet, blister pack

sandoz pty ltd - olanzapine, quantity: 7.5 mg - tablet, film coated - excipient ingredients: crospovidone; lactose monohydrate; hyprolose; magnesium stearate; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - treatment of schizophrenia and related psychoses. short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder. preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

OLANZAPINE SANDOZ olanzapine 5mg film coated tablet, blister pack Australia - englanti - Department of Health (Therapeutic Goods Administration)

olanzapine sandoz olanzapine 5mg film coated tablet, blister pack

sandoz pty ltd - olanzapine, quantity: 5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; hyprolose; lactose monohydrate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - treatment of schizophrenia and related psychoses. short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder. preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

OLANZAPINE SANDOZ olanzapine 10mg film coated tablet, blister pack Australia - englanti - Department of Health (Therapeutic Goods Administration)

olanzapine sandoz olanzapine 10mg film coated tablet, blister pack

sandoz pty ltd - olanzapine, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hyprolose; magnesium stearate; crospovidone; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - treatment of schizophrenia and related psychoses. short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder. preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.